Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
Beach
J E
JE
Hyman, Phelps & McNamara, P.C., Washington, D.C., USA.
Faich
G A
GA
Bormel
F G
FG
Sasinowski
F J
FJ
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D004346:Drug Information Services / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000145:classification / Q000331:legislation & jurisprudence; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007880:Legislation, Drug; D016365:Liability, Legal; D014481:United States; D014486:United States Food and Drug Administration; D014635:Valproic Acid / Q000009:adverse effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D014635:Valproic Acid